Hormonal resuscitation and p38 MAP kinase inhibition to enhance quality of cadaveric donor organs for transplantation [ 2005 - 2007 ]

Research Grant

Researchers: Prof Peter Macdonald (Principal investigator) ,  Dr Graham Stewart ,  Dr Mark Hicks ,  Dr Michael Wilson

Brief description The transplantation of organs such as the heart, lung, liver, kidney and pancreas from brain-dead donors is limited primarily by the shortage of donor organs. It is now recognised that as many as 25% (one in four) potentially usuable donor organs are lost after brain death due to the rapid deterioration that occurs in organs after brain death. There is evidence that this deterioration is due to loss of the normal hormones that are essential to the normal functioning of these organs. In this project, we will use a pig model of brain death that we have extablished in our laboratory to examine the effects of hormone replacement on the function of organs that are used for transplantation. We will also test a novel drug aimed at protecting donor organs during the period between removal of the organ and transplantation. If successful, these treatments have the potential to markedly increase the numbers of organ transplants and to improve the outcomes for recipients of these transplants. In the Australian and New Zealand setting, a 25% increase in the number of donor organs would results in approximately 220 more people per year receiving these life-saving operations.

Funding Amount $AUD 469,500.00

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant